Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Stroke

  Free Subscription


Articles published in Eur Heart J

Retrieve available abstracts of 101 articles:
HTML format
Text format



Single Articles


    May 2018
  1. YANG H, Nassif M, Khairy P, de Groot JR, et al
    Cardiac diagnostic work-up of ischaemic stroke.
    Eur Heart J. 2018;39:1851-1860.
    PubMed     Text format     Abstract available


  2. LIBERALE L, Diaz-Canestro C, Bonetti NR, Paneni F, et al
    Post-ischaemic administration of the murine Canakinumab-surrogate antibody improves outcome in experimental stroke.
    Eur Heart J. 2018 May 16. pii: 4996878. doi: 10.1093.
    PubMed     Text format     Abstract available


    April 2018
  3. MAHMOUD KD, Jolly SS, James S, Dzavik V, et al
    Clinical impact of direct stenting and interaction with thrombus aspiration in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention: Thrombectomy Trialists Collaboration.
    Eur Heart J. 2018 Apr 21. pii: 4975836. doi: 10.1093.
    PubMed     Text format     Abstract available


  4. ANDREOTTI F, Navarese EP, Crea F
    Prolonged endogenous fibrinolysis predicts reduced survival after acute coronary syndromes.
    Eur Heart J. 2018;39:1086-1088.
    PubMed     Text format    


    March 2018
  5. LANDMESSER U, Chapman MJ, Stock JK, Amarenco P, et al
    New prospects for PCSK9 inhibition?
    Eur Heart J. 2018 Mar 22. pii: 4951530. doi: 10.1093.
    PubMed     Text format    


    February 2018
  6. FADINI GP, Cosentino F
    Diabetes and ischaemic stroke: a deadly association.
    Eur Heart J. 2018 Feb 9. pii: 4846897. doi: 10.1093.
    PubMed     Text format    


  7. ECHOUFFO-TCHEUGUI JB, Xu H, Matsouaka RA, Xian Y, et al
    Diabetes and long-term outcomes of ischaemic stroke: findings from Get With The Guidelines-Stroke.
    Eur Heart J. 2018 Feb 9. pii: 4846898. doi: 10.1093.
    PubMed     Text format     Abstract available


  8. LANCELLOTTI P, Galderisi M
    Prediction of ischaemic stroke in non-valvular atrial fibrillation if advanced echocardiography plays the game.
    Eur Heart J. 2018 Feb 9. pii: 4847811. doi: 10.1093.
    PubMed     Text format    


    January 2018
  9. BERGMARK BA, Scirica BM, Steg PG, Fanola CL, et al
    Blood pressure and cardiovascular outcomes in patients with diabetes and high cardiovascular risk.
    Eur Heart J. 2018 Jan 31. pii: 4831245. doi: 10.1093.
    PubMed     Text format     Abstract available


    December 2017
  10. LEUNG M, van Rosendael PJ, Abou R, Ajmone Marsan N, et al
    Left atrial function to identify patients with atrial fibrillation at high risk of stroke: new insights from a large registry.
    Eur Heart J. 2017 Dec 28. pii: 4781364. doi: 10.1093.
    PubMed     Text format     Abstract available


    November 2017
  11. DARMON A, Bhatt DL, Elbez Y, Aboyans V, et al
    External applicability of the COMPASS trial: an analysis of the reduction of atherothrombosis for continued health (REACH) registry.
    Eur Heart J. 2017 Nov 23. pii: 4656148. doi: 10.1093.
    PubMed     Text format     Abstract available


  12. STAERK L, Fosbol EL, Lamberts M, Bonde AN, et al
    Resumption of oral anticoagulation following traumatic injury and risk of stroke and bleeding in patients with atrial fibrillation: a nationwide cohort study.
    Eur Heart J. 2017 Nov 18. doi: 10.1093.
    PubMed     Text format     Abstract available


    October 2017
  13. LANDMESSER U, Chapman MJ, Stock JK, Amarenco P, et al
    2017 Update of ESC/EAS Task Force on practical clinical guidance for proprotein convertase subtilisin/kexin type 9 inhibition in patients with atherosclerotic cardiovascular disease or in familial hypercholesterolaemia.
    Eur Heart J. 2017 Oct 16. doi: 10.1093.
    PubMed     Text format    


  14. CALIFF RM
    Finding ideal blood pressure targets in ischaemic stroke: prospective insight or retrospective guesswork?
    Eur Heart J. 2017;38:2836-2837.
    PubMed     Text format    


  15. BANGALORE S, Schwamm L, Smith EE, Hellkamp AS, et al
    Blood pressure and in-hospital outcomes in patients presenting with ischaemic stroke.
    Eur Heart J. 2017;38:2827-2835.
    PubMed     Text format     Abstract available


    September 2017
  16. KIVIMAKI M, Nyberg ST, Batty GD, Kawachi I, et al
    Long working hours as a risk factor for atrial fibrillation: a multi-cohort study.
    Eur Heart J. 2017;38:2621-2628.
    PubMed     Text format     Abstract available


    August 2017
  17. WIDIMSKY P, Doehner W, Diener HC, Van Gelder IC, et al
    The role of cardiologists in stroke prevention and treatment: position paper of the European Society of Cardiology Council on Stroke.
    Eur Heart J. 2017 Aug 28. doi: 10.1093.
    PubMed     Text format    


  18. IBANEZ B, James S, Agewall S, Antunes MJ, et al
    2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European S
    Eur Heart J. 2017 Aug 26. doi: 10.1093.
    PubMed     Text format    


  19. ABOYANS V, Bjorck M, Brodmann M, Collet JP, et al
    Questions and answers on diagnosis and management of patients with Peripheral Arterial Diseases: a companion document of the 2017 ESC Guidelines for the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Societ
    Eur Heart J. 2017 Aug 26. doi: 10.1093.
    PubMed     Text format    


    July 2017
  20. HOPEWELL JC, Malik R, Valdes-Marquez E, Worrall BB, et al
    Differential effects of PCSK9 variants on risk of coronary disease and ischaemic stroke.
    Eur Heart J. 2017 Jul 17. doi: 10.1093.
    PubMed     Text format     Abstract available


    April 2017
  21. SINGH-MANOUX A, Fayosse A, Sabia S, Canonico M, et al
    Atrial fibrillation as a risk factor for cognitive decline and dementia.
    Eur Heart J. 2017 Apr 29. doi: 10.1093.
    PubMed     Text format     Abstract available


  22. CAVALCANTE R, Sotomi Y, Mancone M, Whan Lee C, et al
    Impact of the SYNTAX scores I and II in patients with diabetes and multivessel coronary disease: a pooled analysis of patient level data from the SYNTAX, PRECOMBAT, and BEST trials.
    Eur Heart J. 2017 Apr 18. doi: 10.1093.
    PubMed     Text format     Abstract available


  23. VRANCKX P, Frigoli E, Rothenbuhler M, Tomassini F, et al
    Radial versus femoral access in patients with acute coronary syndromes with or without ST-segment elevation.
    Eur Heart J. 2017;38:1069-1080.
    PubMed     Text format     Abstract available


  24. PALMERINI T, Della Riva D, Benedetto U, Bacchi Reggiani L, et al
    Three, six, or twelve months of dual antiplatelet therapy after DES implantation in patients with or without acute coronary syndromes: an individual patient data pairwise and network meta-analysis of six randomized trials and 11 473 patients.
    Eur Heart J. 2017;38:1034-1043.
    PubMed     Text format     Abstract available


    March 2017
  25. VOLLEMA EM, Kong WK, Katsanos S, Kamperidis V, et al
    Transcatheter aortic valve thrombosis: the relation between hypo-attenuated leaflet thickening, abnormal valve haemodynamics, and stroke.
    Eur Heart J. 2017 Mar 27. doi: 10.1093.
    PubMed     Text format     Abstract available


  26. LI XS, Obeid S, Klingenberg R, Gencer B, et al
    Gut microbiota-dependent trimethylamine N-oxide in acute coronary syndromes: a prognostic marker for incident cardiovascular events beyond traditional risk factors.
    Eur Heart J. 2017;38:814-824.
    PubMed     Text format     Abstract available


  27. ABDUL-RAHIM AH, Perez AC, MacIsaac RL, Jhund PS, et al
    Risk of stroke in chronic heart failure patients with preserved ejection fraction, but without atrial fibrillation: analysis of the CHARM-Preserved and I-Preserve trials.
    Eur Heart J. 2017;38:742-750.
    PubMed     Text format     Abstract available


  28. VAN GELDER IC, Healey JS, Crijns HJ, Wang J, et al
    Duration of device-detected subclinical atrial fibrillation and occurrence of stroke in ASSERT.
    Eur Heart J. 2017 Mar 1. doi: 10.1093.
    PubMed     Text format     Abstract available


    February 2017
  29. PASEA L, Chung SC, Pujades-Rodriguez M, Moayyeri A, et al
    Personalising the decision for prolonged dual antiplatelet therapy: development, validation and potential impact of prognostic models for cardiovascular events and bleeding in myocardial infarction survivors.
    Eur Heart J. 2017 Feb 27. doi: 10.1093.
    PubMed     Text format     Abstract available


  30. MAZZOLAI L, Aboyans V, Ageno W, Agnelli G, et al
    Diagnosis and management of acute deep vein thrombosis: a joint consensus document from the European society of cardiology working groups of aorta and peripheral circulation and pulmonary circulation and right ventricular function.
    Eur Heart J. 2017 Feb 17. doi: 10.1093.
    PubMed     Text format    


  31. CIMATO TR
    Persistent stem cell-driven inflammation in patients with prior MI and stroke.
    Eur Heart J. 2017;38:433-435.
    PubMed     Text format    


    January 2017
  32. GADSBOLL K, Staerk L, Fosbol EL, Sindet-Pedersen C, et al
    Increased use of oral anticoagulants in patients with atrial fibrillation: temporal trends from 2005 to 2015 in Denmark.
    Eur Heart J. 2017 Jan 21. pii: ehw658. doi: 10.1093.
    PubMed     Text format     Abstract available


  33. RENOUX C, Coulombe J, Suissa S
    Revisiting sex differences in outcomes in non-valvular atrial fibrillation: a population-based cohort study.
    Eur Heart J. 2017 Jan 10. pii: ehw613. doi: 10.1093.
    PubMed     Text format     Abstract available


  34. REINER MF, Breitenstein A, Holy EW, Glanzmann M, et al
    Ticagrelor, but not clopidogrel active metabolite, displays antithrombotic properties in the left atrial endocardium.
    Eur Heart J. 2017 Jan 8. pii: ehw578. doi: 10.1093.
    PubMed     Text format     Abstract available


  35. FANOLA CL, Giugliano RP, Ruff CT, Trevisan M, et al
    A novel risk prediction score in atrial fibrillation for a net clinical outcome from the ENGAGE AF-TIMI 48 randomized clinical trial.
    Eur Heart J. 2017 Jan 6. pii: ehw565. doi: 10.1093.
    PubMed     Text format     Abstract available


  36. DE CARLO M, Mazzolai L, Bossone E, Brodmann M, et al
    The year in cardiology 2016: peripheral circulation.
    Eur Heart J. 2017 Jan 2. pii: ehw643. doi: 10.1093.
    PubMed     Text format    


  37. GAL P, Marrouche NF
    Magnetic resonance imaging of atrial fibrosis: redefining atrial fibrillation to a syndrome.
    Eur Heart J. 2017;38:14-19.
    PubMed     Text format     Abstract available


    November 2016
  38. YANG H, Nassif M, Khairy P, de Groot JR, et al
    Cardiac diagnostic work-up of ischaemic stroke.
    Eur Heart J. 2016.
    PubMed     Text format     Abstract available


    October 2016
  39. TARANTINI G, Mojoli M, Urena M, Vahanian A, et al
    Atrial fibrillation in patients undergoing transcatheter aortic valve implantation: epidemiology, timing, predictors, and outcome.
    Eur Heart J. 2016.
    PubMed     Text format     Abstract available


  40. GUDBJARTSSON DF, Holm H, Sulem P, Masson G, et al
    A frameshift deletion in the sarcomere gene MYL4 causes early-onset familial atrial fibrillation.
    Eur Heart J. 2016.
    PubMed     Text format     Abstract available


  41. STAERK L, Fosbol EL, Lip GY, Lamberts M, et al
    Ischaemic and haemorrhagic stroke associated with non-vitamin K antagonist oral anticoagulants and warfarin use in patients with atrial fibrillation: a nationwide cohort study.
    Eur Heart J. 2016.
    PubMed     Text format     Abstract available



  42. Racing against time in acute ischaemic stroke treatment.
    Eur Heart J. 2016;37:2856-2857.
    PubMed     Text format    


    September 2016
  43. PICCINI JP, Sievert H, Patel MR
    Left atrial appendage occlusion: rationale, evidence, devices, and patient selection.
    Eur Heart J. 2016.
    PubMed     Text format     Abstract available


    June 2016
  44. BASSAND JP, Accetta G, Camm AJ, Cools F, et al
    Two-year outcomes of patients with newly diagnosed atrial fibrillation: results from GARFIELD-AF.
    Eur Heart J. 2016.
    PubMed     Text format     Abstract available


  45. FERREIRA JP, Girerd N, Alshalash S, Konstam MA, et al
    Antithrombotic therapy in heart failure patients with and without atrial fibrillation: update and future challenges.
    Eur Heart J. 2016.
    PubMed     Text format     Abstract available


    April 2016
  46. SANDHU RK, Ezekowitz J, Andersson U, Alexander JH, et al
    The 'obesity paradox' in atrial fibrillation: observations from the ARISTOTLE (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation) trial.
    Eur Heart J. 2016.
    PubMed     Text format     Abstract available


    March 2016
  47. LUSCHER TF, Sudano I
    SPRINT: the race for optimal blood pressure control.
    Eur Heart J. 2016;37:937-41.
    PubMed     Text format    


  48. FRIBERG L, Tabrizi F, Englund A
    Catheter ablation for atrial fibrillation is associated with lower incidence of stroke and death: data from Swedish health registries.
    Eur Heart J. 2016.
    PubMed     Text format     Abstract available


  49. FOX KA
    CardioPulse: Anticoagulants reduce risk of death in atrialfibrillation patients by 38%.
    Eur Heart J. 2016;37:860-1.
    PubMed     Text format    


  50. SVENSSON T, Inoue M, Sawada N, Yamagishi K, et al
    Coping strategies and risk of cardiovascular disease incidence and mortality: the Japan Public Health Center-based prospective Study.
    Eur Heart J. 2016;37:890-9.
    PubMed     Text format     Abstract available


  51. STOEKENBROEK RM, Boekholdt SM, Luben R, Hovingh GK, et al
    Heterogeneous impact of classic atherosclerotic risk factors on different arterial territories: the EPIC-Norfolk prospective population study.
    Eur Heart J. 2016;37:880-9.
    PubMed     Text format     Abstract available


  52. RANTHE MF, Diaz LJ, Behrens I, Bundgaard H, et al
    Association between pregnancy losses in women and risk of atherosclerotic disease in their relatives: a nationwide cohort studydagger.
    Eur Heart J. 2016;37:900-7.
    PubMed     Text format     Abstract available


  53. WAKSMAN R, Rogers T
    CardioPulse: Transcatheter aortic valve replacement.The American perspective on transcatheter aortic valve replacement.
    Eur Heart J. 2016;37:797-9.
    PubMed     Text format    


  54. ASPBERG S, Chang Y, Atterman A, Bottai M, et al
    Comparison of the ATRIA, CHADS2, and CHA2DS2-VASc stroke risk scores in predicting ischaemic stroke in a large Swedish cohort of patients with atrial fibrillation.
    Eur Heart J. 2016.
    PubMed     Text format     Abstract available


    February 2016
  55. HIJAZI Z, Lindback J, Alexander JH, Hanna M, et al
    The ABC (age, biomarkers, clinical history) stroke risk score: a biomarker-based risk score for predicting stroke in atrial fibrillation.
    Eur Heart J. 2016.
    PubMed     Text format     Abstract available


  56. GANESAN AN, Chew DP, Hartshorne T, Selvanayagam JB, et al
    The impact of atrial fibrillation type on the risk of thromboembolism, mortality, and bleeding: a systematic review and meta-analysis.
    Eur Heart J. 2016.
    PubMed     Text format     Abstract available


  57. TRUCHANOWICZ E, Kirchhof P
    CardioPulse: New perspectives for stroke prevention in atrial fibrillation.
    Eur Heart J. 2016;37:583-4.
    PubMed     Text format    


  58. STEFFEL J, Jais P, Hindricks G
    The year in cardiology 2015: arrhythmias and device therapy.
    Eur Heart J. 2016;37:587-93.
    PubMed     Text format    


  59. DIENER HC, Aisenberg J, Ansell J, Atar D, et al
    Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 2.
    Eur Heart J. 2016.
    PubMed     Text format     Abstract available


  60. DIENER HC, Aisenberg J, Ansell J, Atar D, et al
    Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 1.
    Eur Heart J. 2016.
    PubMed     Text format     Abstract available


    January 2016
  61. IUNG B, Rahimtoola SH, Vahanian A
    The year in cardiology 2015: valvular heart disease.
    Eur Heart J. 2016.
    PubMed     Text format    


    November 2015
  62. MANCIA G, Kjeldsen SE, Zappe DH, Holzhauer B, et al
    Cardiovascular outcomes at different on-treatment blood pressures in the hypertensive patients of the VALUE trial.
    Eur Heart J. 2015.
    PubMed     Text format     Abstract available


  63. HAMM CW, Arsalan M, Mack MJ
    The future of transcatheter aortic valve implantation.
    Eur Heart J. 2015.
    PubMed     Text format     Abstract available


    October 2015
  64. WIDIMSKY P, Hopkins LN
    Catheter-based interventions for acute ischaemic stroke.
    Eur Heart J. 2015.
    PubMed     Text format     Abstract available


    September 2015
  65. O'BRIEN EC, Simon DN, Thomas LE, Hylek EM, et al
    The ORBIT bleeding score: a simple bedside score to assess bleeding risk in atrial fibrillation.
    Eur Heart J. 2015.
    PubMed     Text format     Abstract available


  66. KOTECHA D, Piccini JP
    Atrial fibrillation in heart failure: what should we do?
    Eur Heart J. 2015.
    PubMed     Text format     Abstract available


  67. SKOLOUDIK D, Kuliha M, Hrbac T, Jonszta T, et al
    Sonolysis in Prevention of Brain Infarction During Carotid Endarterectomy and Stenting (SONOBUSTER): a randomized, controlled trial.
    Eur Heart J. 2015.
    PubMed     Text format     Abstract available


  68. LUSCHER TF
    Stroke: cardiac causes and their management.
    Eur Heart J. 2015;36:2339-41.
    PubMed     Text format    


  69. KENT DM, Dahabreh IJ, Ruthazer R, Furlan AJ, et al
    Anticoagulant vs. antiplatelet therapy in patients with cryptogenic stroke and patent foramen ovale: an individual participant data meta-analysis.
    Eur Heart J. 2015;36:2381-9.
    PubMed     Text format     Abstract available


  70. SARDAR P, Chatterjee S, Giri J, Kundu A, et al
    Endovascular therapy for acute ischaemic stroke: a systematic review and meta-analysis of randomized trials.
    Eur Heart J. 2015;36:2373-80.
    PubMed     Text format     Abstract available


  71. VINEREANU D, Stevens SR, Alexander JH, Al-Khatib SM, et al
    Clinical outcomes in patients with atrial fibrillation according to sex during anticoagulation with apixaban or warfarin: a secondary analysis of a randomized controlled trial.
    Eur Heart J. 2015.
    PubMed     Text format     Abstract available


  72. LIP GY
    The CHA2DS2-VASc score for stroke risk stratification in patients with atrial fibrillation: a brief history.
    Eur Heart J. 2015.
    PubMed     Text format    


  73. LIP GY, Lane DA
    Assessing bleeding risk in atrial fibrillation with the HAS-BLED and ORBIT scores: clinical application requires focus on the reversible bleeding risk factors.
    Eur Heart J. 2015.
    PubMed     Text format    


  74. CAMM AJ, Amarenco P, Haas S, Hess S, et al
    XANTUS: a real-world, prospective, observational study of patients treated with rivaroxaban for stroke prevention in atrial fibrillation.
    Eur Heart J. 2015.
    PubMed     Text format     Abstract available


    August 2015
  75. BARBASH IM, Barbanti M, Webb J, Molina-Martin De Nicolas J, et al
    Comparison of vascular closure devices for access site closure after transfemoral aortic valve implantation.
    Eur Heart J. 2015.
    PubMed     Text format     Abstract available


  76. SHARMA R, Oni OA, Gupta K, Chen G, et al
    Normalization of testosterone level is associated with reduced incidence of myocardial infarction and mortality in men.
    Eur Heart J. 2015.
    PubMed     Text format     Abstract available


  77. TAYLOR J
    Hand grip strength predicts myocardial infarction and stroke.
    Eur Heart J. 2015;36:1845.
    PubMed     Text format    


    July 2015
  78. STONE GW, Adams DH, Abraham WT, Kappetein AP, et al
    Clinical trial design principles and endpoint definitions for transcatheter mitral valve repair and replacement: part 2: endpoint definitions: A consensus document from the Mitral Valve Academic Research Consortium.
    Eur Heart J. 2015.
    PubMed     Text format     Abstract available


  79. DENEGRI A, Pedrazzini GB, Moccetti T, Moccetti M, et al
    Calcification of the mitral valve complicated by embolization and subsequent ischemic stroke with haemorrhagic transformation.
    Eur Heart J. 2015.
    PubMed     Text format    


  80. LUSCHER TF MD FESC
    Novel risk markers and mediators in coronary disease and stroke.
    Eur Heart J. 2015;36:1557-1559.
    PubMed     Text format    


  81. JAMES S
    Stroke: a rare but devastating procedural complication of PCI.
    Eur Heart J. 2015;36:1571-2.
    PubMed     Text format    


  82. VOLPE M, Paneni F
    Shooting vascular oxidative stress: new hopes for stroke patients?
    Eur Heart J. 2015;36:1573-5.
    PubMed     Text format    


  83. SPESCHA RD, Klohs J, Semerano A, Giacalone G, et al
    Post-ischaemic silencing of p66Shc reduces ischaemia/reperfusion brain injury and its expression correlates to clinical outcome in stroke.
    Eur Heart J. 2015;36:1590-600.
    PubMed     Text format     Abstract available


    June 2015
  84. JOLLY SS, Cairns JA, Yusuf S, Meeks B, et al
    Stroke in the TOTAL trial: a randomized trial of routine thrombectomy vs. percutaneous coronary intervention alone in ST elevation myocardial infarction.
    Eur Heart J. 2015.
    PubMed     Text format     Abstract available


  85. POKORNEY SD, Granger CB
    Should patients on vitamin K antagonists be treated differently?
    Eur Heart J. 2015;36:1431-3.
    PubMed     Text format    


  86. O'DONOGHUE ML, Ruff CT, Giugliano RP, Murphy SA, et al
    Edoxaban vs. warfarin in vitamin K antagonist experienced and naive patients with atrial fibrillationdagger.
    Eur Heart J. 2015;36:1470-7.
    PubMed     Text format     Abstract available


  87. LANZER P, Widimsky P
    Ischaemic stroke and ST-segment elevation myocardial infarction: fast-track single-stop approach.
    Eur Heart J. 2015.
    PubMed     Text format    


    May 2015
  88. COSTA F, Vranckx P, Leonardi S, Moscarella E, et al
    Impact of clinical presentation on ischaemic and bleeding outcomes in patients receiving 6- or 24-month duration of dual-antiplatelet therapy after stent implantation: a pre-specified analysis from the PRODIGY (Prolonging Dual-Antiplatelet Treatment A
    Eur Heart J. 2015;36:1242-51.
    PubMed     Text format     Abstract available


  89. SCHULZ-SCHUPKE S, Byrne RA, Ten Berg JM, Neumann FJ, et al
    ISAR-SAFE: a randomized, double-blind, placebo-controlled trial of 6 vs. 12 months of clopidogrel therapy after drug-eluting stenting.
    Eur Heart J. 2015;36:1252-63.
    PubMed     Text format     Abstract available


  90. PHILIPPART R, Brunet-Bernard A, Clementy N, Bourguignon T, et al
    Prognostic value of CHA2DS2-VASc score in patients with 'non-valvular atrial fibrillation' and valvular heart disease: the Loire Valley Atrial Fibrillation Project.
    Eur Heart J. 2015.
    PubMed     Text format     Abstract available


  91. JERNBERG T, Hasvold P, Henriksson M, Hjelm H, et al
    Cardiovascular risk in post-myocardial infarction patients: nationwide real world data demonstrate the importance of a long-term perspective.
    Eur Heart J. 2015;36:1163-70.
    PubMed     Text format     Abstract available


  92. STEFFEL J, Giugliano RP, Braunwald E, Murphy SA, et al
    Edoxaban vs. warfarin in patients with atrial fibrillation on amiodarone: a subgroup analysis of the ENGAGE AF-TIMI 48 trial.
    Eur Heart J. 2015.
    PubMed     Text format     Abstract available


  93. KARANASOS A, Van Mieghem NM, Regar E, Daemen J, et al
    Serial imaging observations of vascular healing in a denervation-induced renal artery dissection.
    Eur Heart J. 2015;36:1040.
    PubMed     Text format    


  94. VAN DER DONCKT C, Van Herck JL, Schrijvers DM, Vanhoutte G, et al
    Elastin fragmentation in atherosclerotic mice leads to intraplaque neovascularization, plaque rupture, myocardial infarction, stroke, and sudden death.
    Eur Heart J. 2015;36:1049-58.
    PubMed     Text format     Abstract available


    April 2015
  95. KWOK CS, Kontopantelis E, Myint PK, Zaman A, et al
    Stroke following percutaneous coronary intervention: type-specific incidence, outcomes and determinants seen by the British Cardiovascular Intervention Society 2007-12.
    Eur Heart J. 2015.
    PubMed     Text format     Abstract available


    March 2015
  96. LANZER P
    CardioPulse: STEMI and stroke: distant cousins at best.
    Eur Heart J. 2015;36:590.
    PubMed     Text format    


    February 2015
  97. ALIOT E, Brandes A, Eckardt L, Elvan A, et al
    The EAST study: redefining the role of rhythmcontrol therapy in atrial fibrillation: EAST, the Early treatment of Atrial fibrillation for Stroke prevention Trial.
    Eur Heart J. 2015;36:255-6.
    PubMed     Text format    


  98. HEIDBUCHEL H, Hindricks G
    The year in cardiology 2014: arrhythmias and device therapy.
    Eur Heart J. 2015;36:270-8.
    PubMed     Text format     Abstract available


    January 2015
  99. CREMONESI A, Castriota F, Secco GG, Macdonald S, et al
    Carotid artery stenting: an update.
    Eur Heart J. 2015;36:13-21.
    PubMed     Text format     Abstract available


    December 2014
  100. TANIWAKI M, Windecker S, Raber L
    Silent myocardial infarction and stroke: findings of multimodality imaging.
    Eur Heart J. 2014.
    PubMed     Text format    


  101. HELD C, Hylek EM, Alexander JH, Hanna M, et al
    Clinical outcomes and management associated with major bleeding in patients with atrial fibrillation treated with apixaban or warfarin: insights from the ARISTOTLE trial.
    Eur Heart J. 2014.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Stroke is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: